Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 14, 2026
Bath & Body Works (BBWI): What to Expect from Q1 Fiscal 2026 Earnings

Bath & Body Works (BBWI): What to Expect from Q1 Fiscal 2026 Earnings

Key Takeaways

  • Analysts expect Q1 fiscal 2026 adjusted EPS of $0.29, aligning with company guidance of $0.24-$0.30.
  • Consensus revenue forecast is $1.36 billion, down about 4.5% from $1.424 billion in Q1 last year, matching guided 4%-6% decline.
  • Key metrics to watch include gross profit rate around 42.5% amid tariff headwinds (about 150 basis points), adjusted SG&A rate near 32.3%, and buy-and-other dollars.
  • Fiscal 2026 full-year guidance signals net sales down 2.5%-4.5% and adjusted EPS $2.40-$2.65, reflecting cautious consumer spending.
  • BBWI has beaten EPS estimates in recent quarters, including Q4 2025's $2.05 vs. $1.77 expected.
  • Investor focus on progress in "Consumer First Formula" strategy amid softer retail demand.

Earnings Context and Why It Matters

As we approach the Bath & Body Works (BBWI) Q1 fiscal 2026 earnings report on May 27, 2026, I'm paying close attention to how this specialty retailer of personal care and home fragrance products is navigating broader retail headwinds. Budget-conscious consumers are pulling back on non-essentials like fragrances and candles, driven by rising living costs and a softening labor market. After delivering an adjusted EPS beat of $2.05 against $1.77 expected in Q4 2025—despite flat full-year sales—this report could signal whether stabilization is underway. In my view, it will provide key insights into the early execution of the "Consumer First Formula," which prioritizes innovation in core categories, even as guided sales declines persist. For investors, the focus will be on margin resilience, tariff impacts, and demand trends in the competitive beauty sector.

Earnings Expectations

Wall Street's consensus points to Q1 fiscal 2026 revenue—ending around early May 2026—of $1.36 billion, a roughly 4.5% year-over-year decline from $1.424 billion in Q1 fiscal 2025. This aligns neatly with the company's guidance for a 4%-6% drop. Adjusted EPS is expected at $0.29 according to 15 analysts, fitting within BBWI's outlook of $0.24-$0.30 (or reported EPS of $0.84-$0.90), compared to $0.49 in Q1 2025.

One thing that stands out is the scrutiny on gross margins, projected around 42.5% and pressured by about 150 basis points from tariffs, alongside an adjusted SG&A rate near 32.3% and flat buy-and-other dollars. Looking ahead, full-year fiscal 2026 guidance calls for net sales down 2.5%-4.5% to about $7.0 billion and adjusted EPS of $2.40-$2.65. This assumes no share repurchases and around $600 million in free cash flow. Historically, BBWI has a strong track record of EPS beats, as seen in Q4 2025, though stock reactions can vary—recent results showed initial gains tempered by softer guidance.

Market Reaction and Investor Sentiment

Sentiment around BBWI remains cautious heading into these earnings, with shares under pressure from broader retail challenges and the conservative fiscal 2026 guidance issued after Q4. Analysts highlight risks like heightened promotional intensity and value-oriented consumer behavior, but the company's 100% EPS beat rate in recent quarters offers some balance. Tariff headwinds—around 150 basis points to Q1 gross margins—and softer body care demand are concerns, though home fragrance strengths provide an offset. After Q4, the stock rose initially on the beat but retraced on guidance, underscoring its sensitivity to the forward outlook. From what I see, pre-earnings positioning will likely depend on updates to the Consumer First strategy.

Why I Use Tickeron’s AI Screener

In my own research process, I’ve found Tickeron’s AI Screener particularly useful for digging into stocks like BBWI. This AI-powered tool lets me filter thousands of stocks and ETFs based on technical patterns, fundamentals, trends, volatility, and AI-driven signals—using customizable criteria like industry, market cap, indicators, price patterns, and performance metrics. It streamlines identifying trade ideas, breakout candidates, and opportunities in sectors like retail far more efficiently than manual methods. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry, and it’s helped sharpen my perspective on relative positioning.

Forward Outlook and Key Factors to Monitor

Post-Q1, I'll be watching how closely BBWI adheres to its fiscal 2026 guidance: net sales down 2.5%-4.5% and adjusted EPS of $2.40-$2.65. This factors in moves like redeeming $284 million in January 2027 bonds to save on interest and generating about $600 million in free cash flow, with no repurchases assumed.

Progress on the "Consumer First Formula" is core here, with plans to ramp product innovation in the second half of 2026 through upgraded packaging, higher fragrance loads, and efficacy claims in body care and home fragrance. Management expects about 1% square footage growth, mid-to-high single-digit international sales increases, and lifts from expanded distribution such as Amazon—around $50 million or a 0.5-point sales boost.

Macro factors include ongoing consumer caution on non-essentials due to cost-of-living pressures, flat promotional intensity, and neutral year-over-year tariff impacts. Margin details—gross rate around 42.4% under 130 basis points of pressure, adjusted SG&A at about 29.2%—along with non-operating expenses of roughly $230 million and a 26.5% tax rate, will indicate operational strength. This is important because execution on Fuel for Growth savings (about $175 million in 2026), CapEx around $270 million, and category shifts—like scaling back laundry to prioritize fragrances—will be telling amid demand resets. I’m watching this closely for signs of resilience.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BBWI

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


BBWI in downward trend: 10-day moving average crossed below 50-day moving average on August 11, 2026

The 10-day moving average for BBWI crossed bearishly below the 50-day moving average on August 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BBWI as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BBWI moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBWI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BBWI entered a downward trend on August 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BBWI's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where BBWI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BBWI just turned positive on August 21, 2026. Looking at past instances where BBWI's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for BBWI moved above the 200-day moving average on August 12, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBWI advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

BBWI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (5.059). P/E Ratio (5.526) is within average values for comparable stocks, (38.427). Projected Growth (PEG Ratio) (0.751) is also within normal values, averaging (1.492). Dividend Yield (0.041) settles around the average of (0.030) among similar stocks. P/S Ratio (0.552) is also within normal values, averaging (1.151).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BBWI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBWI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ulta Beauty (NASDAQ:ULTA), Tractor Supply Co (NASDAQ:TSCO), Best Buy Company (NYSE:BBY), Five Below (NASDAQ:FIVE), GameStop Corp (NYSE:GME), Bath & Body Works (NYSE:BBWI), RH (NYSE:RH), 1-800-FLOWERS.COM (NASDAQ:FLWS).

Industry description

The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.

Market Cap

The average market capitalization across the Specialty Stores Industry is 4.52B. The market cap for tickers in the group ranges from 4.65K to 52.32B. ANCTF holds the highest valuation in this group at 52.32B. The lowest valued company is SIMPQ at 4.65K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Stores Industry was -2%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -6%. ABLV experienced the highest price growth at 27%, while RH experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Specialty Stores Industry was -8%. For the same stocks of the Industry, the average monthly volume growth was 23% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 58
Price Growth Rating: 58
SMR Rating: 64
Profit Risk Rating: 88
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
BBWI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of retail business

Industry SpecialtyStores

Profile
Details
Industry
Apparel Or Footwear Retail
Address
Three Limited Parkway
Phone
+1 614 415-7000
Employees
57157
Web
https://www.bbwinc.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
Bath & Body Works (BBWI): What to Expect from Q1 Fiscal 2026 Earnings